Press release
Hematological Malignancies Drugs Market Trends Reveal Rising Adoption of Precision Medicine and Advanced Immunotherapies Globally
Hematological Malignancies Drugs Market
The Hematological Malignancies Drugs Market Size is estimated to grow at a CAGR of 14.2% during the forecast period for 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1211
Hematological malignancies are cancers that affect the bone marrow, lymph nodes, and blood, encompassing myeloma, leukemia, and lymphoma, with lymphoma representing the most common subtype. Advances in treatment outcomes for these cancers have been driven by the development and utilization of novel targeted therapies, including small molecule inhibitors, monoclonal antibodies, bispecific T-cell engagers, antibody-drug conjugates, recombinant immunotoxins, and Chimeric Antigen Receptor T (CAR-T) cell therapies.
The growth of the hematological malignancies drug market is supported by several factors, including increased research and development activities aimed at innovative cancer treatments, the integration of precision medicine approaches in managing hematological cancers, a rising number of regulatory approvals for therapies targeting various hematological malignancies, and significant progress in targeted treatments for leukemia and lymphoma. The market demand is expected to rise in response to the growing incidence of leukemia and lymphoma. However, market expansion may face challenges due to high treatment and product costs, adverse therapeutic side effects, restrictive reimbursement policies, and safety concerns, which could limit growth in the coming years.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04
North America is anticipated to be the major contributor to the Hematological Malignancies Drugs market over the forecast years due to the rising rates of leukemia and lymphoma in this area and the rising R&D spending for cancer therapies. In addition, the Asia Pacific regional market is expected to register significant growth during the estimated period. The market is expected to rise due to rising financing for cancer research, a high incidence of blood cancers, and an increased demand for efficient treatments.
Major market players operating in the Hematological Malignancies Drugs market include
AbbVie Inc., Amgen Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc., GlaxoSmithKline plc, Immune-Onc Therapeutics, Inc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis International AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, and others.
Recent collaborations and agreements in the market:
• In October 2021, for treating chronic myeloid leukemia (CML), Novartis received the US FDA's approval of Scemblix (asciminib) for two different indications.
• In September 2021, results from the dose-escalation portion of the Phase 1/2 EPCORE NHL-1 first-in-human (FIH) dose-escalation and cohort expansion clinical trial, which evaluated the safety and early efficacy of the investigational therapy epcoritamab (DuoBody-CD3xCD20) in patients with B-cell non-lymphoma Hodgkin's that had relapsed or been resistant to treatment, was released by AbbVie and Genma (B-NHL).
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1211
Market Segments
Global Hematological Malignancies Drugs Market, by Drugs, 2022-2030 (Value US$ Mn)
• Monoclonal Antibodies
o Blincyto (Blinatumomab)
o Besponsa (Inotuzumab Ozogamicin)
o Lumoxiti (Moxetumomab Pasudotox)
o Mylotarg (Gemtuzumab Ozogamicin)
o Opdivo (Nivolumab)
o AiRuiKa (Camrelizumab)
o Tyvyt (Sintilimab)
o Tislelizumab
o Gazyva (Obinutuzumab)
o Zynlonta (Loncastuximab Tesirine-lpyl)
o Darzalex (Daratumumab)
o Blenrep (Belantamab Mafodotin-blmf)
o Keytruda (Pembrolizumab)
o Adcetris (Brentuximab Vedotin)
o Arzerra (Ofatumumab
• CAR-T Cell Therapy
o Tecartus (Brexucabtagene Autoleucel)
o Kymriah (Tisagenlecleucel)
o Yescarta (Axicabtagene Ciloleucel)
o Breyanzi (Lisocabtagene Maraleucel)
o Abecma (Idecabtagene Vicleucel)
Global Hematological Malignancies Drugs Market, by Pipeline Products, 2022-2030 (Value US$ Mn)
• Monoclonal Antibodies
o Teclistamab
o Iomab-B
o Ublituximab
o CS1001
• CAR-T Cell Therapy
o Ciltacabtagene Autoleucel (JNJ-68284528)
Global Hematological Malignancies Drugs Market, by Indications, 2022-2030 (Value US$ Mn)
• Leukemia
o Acute Lymphoblastic Leukemia
o Chronic Lymphoblastic Leukemia
o Acute Myeloid Leukemia
• Lymphoma
o Hodgkin's Lymphoma
o Non-Hodgkin's Lymphoma
• Multiple Myeloma
Global Hematological Malignancies Drugs Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Hematological Malignancies Drugs Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Hematological Malignancies Drugs Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Hematological Malignancies Drugs Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Hematological Malignancies Drugs Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Hematological Malignancies Drugs Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global Hematological Malignancies Drugs market
To receive an industry overview and future trends of the Hematological Malignancies Drugs market
To analyze the Hematological Malignancies Drugs market drivers and challenges
To get information on the Hematological Malignancies Drugs market value (US$ Mn) forecast to 2030
Significant investments, mergers & acquisitions in the Hematological Malignancies Drugs market industry
Read Overview Report- https://www.insightaceanalytic.com/report/global-hematological-malignancies-drugs-market--/1211
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hematological Malignancies Drugs Market Trends Reveal Rising Adoption of Precision Medicine and Advanced Immunotherapies Globally here
News-ID: 4022859 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market to Grow at 5 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market- (By Product Type (Combined Nutritional Supplements, Single Nutritional Supplements), By Type Indication (Perimenopause, PMS), By Formulation (Capsules/Tablets, Powder, Softgels, Other), By Sales Channel (Pharmacies/Drug Stores, Online Sales Channel, Direct Sales Channel, Others)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research…
Cell and Gene Therapy CRO Market Forecast Shows Robust Growth Across North Ameri …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cell and Gene Therapy CRO Market- (By Type of Cell Therapy (CAR-NK, CAR-T, TCR-T, and Others), By Type of Genetic Modification (Ex vivo and In vivo), By Stage of Development (Discovery, Preclinical, and Clinical)), By Therapeutic Area, By End-user, By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by…
Bioseparation Systems Market Top Companies Study - GE Healthcare Life Sciences, …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Bioseparation Systems Market- (By Type (Centrifugation Technology, Cell Disruption Technology, Chromatography Technique, Extraction Technique, Filtration Technologies and Membrane-based Bioseparation and Precipitation), Application (Food, Life Sciences, Pharmaceutical and Biopharmaceutical)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Bioseparation Systems Market is valued at US$…
Medical Nutrition Market Key Players Analysis - Abbott Laboratories; Pfizer Inc. …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Global Medical Nutrition Market Size, Share & Trends Analysis Report By Nutrition Type (Proteins, Carbohydrates, Multivitamins & Antioxidants, Amino Acids, Fibers, Minerals), By Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes), By Patient Type (Infants, Adults, And Geriatric Populations), Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes), End-User (Home Care Settings, Long-Term Care Facilities, And Ambulatory Surgical…
More Releases for Drugs
Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded…
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol…
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…
